Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HaoYue Capital, frequently referred to as Howell Capital in English-speaking financial markets, is a premier healthcare-focused investment bank and private equity firm based in China. Founded in 2014, the firm specializes in providing financial advisory services, including private placements and mergers and acquisitions, specifically for the life sciences and healthcare sectors. HaoYue covers a broad spectrum of industries such as biopharmaceuticals, medical technology, healthcare services, and digital health. It is recognized for its deep industry expertise and has facilitated significant capital raises and strategic transactions for numerous leading Chinese healthcare enterprises. The firm is consistently ranked as one of the most active financial advisors in the Asian healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Howell Capital.